Brand dossier
Abbzorb
Historical Abbzorb / Protrition India line. Delhi HC interim injunction restrained use of the ABBZORB mark vs Sun Pharma’s ABZORB — trademark/legal risk, not a protein-quality lab finding.
- Warning-level evidence on record pulls the score down from 100.
- Evidence confidence is 43%; single-source coverage is capped at 60%, so corroboration is still limited.
Evidence confidence
43%
Published products
0
Model
v2.2
Latest verified
Pending
How this brand score is computed
Assessment transparency
Model v2.2: avoid requires sourced critical/negative risk evidence; caution is for material unresolved warnings; under-reviewed brands without allegations stay pending rather than caution.
Final
37/100
Support
0
Warning
1
Critical
0
Confidence 43% · Net sourced impact -14
Calculation steps
50 + 50 × (support − risk) / (support + risk + 40)
Support weight 0 · Risk weight 14 · Evidence prior 40
Base prior
Neutral starting point before sourced evidence
50
Evidence adjustment
50 × (0 − 14) / (0 + 14 + 40)
-13
Final assessment
Published brand score from the snapshot formula
37/100
authenticity
Trademark injunction (ABBZORB mark)
-14
Why not 100
- Warning-level evidence on record pulls the score down from 100.
- Evidence confidence is 43%; single-source coverage is capped at 60%, so corroboration is still limited.
- Limited corroboration keeps scores away from extremes under the current evidence prior.
Brand evidence ledger
Sourced support, warnings, and critical findings for this brand. Missing evidence stays missing.
Product assessment
37 / 100
Caution
Authenticity
Trademark injunction (ABBZORB mark)
Medical Dialogues reports Delhi HC interim relief restraining a Delhi firm from using ABBZORB for health supplements similar to Sun Pharma’s ABZORB.
Evidence confidence 43%
Assessment 37 / 100
Reviewed products
0 in catalog
No published products for this brand are in the catalog yet.